Confluence Investment Management LLC boosted its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.1% during the third quarter, Holdings Channel reports. The institutional investor owned 199,252 shares of the company’s stock after buying an additional 4,190 shares during the period. Confluence Investment Management LLC’s holdings in Thermo Fisher Scientific were worth $31,693,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. American Research & Management Co. raised its stake in Thermo Fisher Scientific by 540.0% in the third quarter. American Research & Management Co. now owns 640 shares of the company’s stock valued at $102,000 after buying an additional 540 shares during the period. Mycio Wealth Partners LLC raised its position in shares of Thermo Fisher Scientific by 1.6% in the second quarter. Mycio Wealth Partners LLC now owns 711 shares of the company’s stock worth $105,000 after buying an additional 11 shares during the period. Signaturefd LLC raised its position in shares of Thermo Fisher Scientific by 10.6% in the second quarter. Signaturefd LLC now owns 842 shares of the company’s stock worth $124,000 after buying an additional 81 shares during the period. Penserra Capital Management LLC raised its position in shares of Thermo Fisher Scientific by 100.0% in the third quarter. Penserra Capital Management LLC now owns 864 shares of the company’s stock worth $137,000 after buying an additional 432 shares during the period. Finally, Argentus Capital Management LLC acquired a new position in shares of Thermo Fisher Scientific during the third quarter worth approximately $183,000. Institutional investors and hedge funds own 86.28% of the company’s stock.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) traded down 0.26% during trading on Tuesday, reaching $139.95. The company’s stock had a trading volume of 416,613 shares. The company’s 50 day moving average price is $149.29 and its 200-day moving average price is $151.92. Thermo Fisher Scientific Inc. has a 1-year low of $119.75 and a 1-year high of $160.68. The stock has a market cap of $55.28 billion, a P/E ratio of 27.97 and a beta of 1.24.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.97 by $0.06. The business earned $4.49 billion during the quarter, compared to analysts’ expectations of $4.39 billion. Thermo Fisher Scientific had a return on equity of 14.95% and a net margin of 11.10%. The firm’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period last year, the firm posted $1.80 EPS. Equities analysts forecast that Thermo Fisher Scientific Inc. will post $8.25 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, January 16th. Investors of record on Thursday, December 15th will be issued a dividend of $0.15 per share. The ex-dividend date is Tuesday, December 13th. This represents a $0.60 annualized dividend and a yield of 0.42%. Thermo Fisher Scientific’s payout ratio is currently 12.00%.

TRADEMARK VIOLATION NOTICE: “Confluence Investment Management LLC Purchases 4,190 Shares of Thermo Fisher Scientific Inc. (TMO)” was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece of content can be accessed at http://www.dailypolitical.com/2016/11/29/confluence-investment-management-llc-purchases-4190-shares-of-thermo-fisher-scientific-inc-tmo.html.

A number of research analysts have recently commented on TMO shares. Bank of America Corp. set a $180.00 price target on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Friday, October 7th. Cleveland Research lowered Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a report on Friday, September 9th. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $172.00 price target for the company in a report on Thursday, October 13th. JPMorgan Chase & Co. started coverage on Thermo Fisher Scientific in a report on Thursday, September 22nd. They set an “overweight” rating and a $180.00 price target for the company. Finally, Leerink Swann reiterated a “buy” rating and set a $175.00 price target on shares of Thermo Fisher Scientific in a report on Sunday, November 20th. Two analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $164.37.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 28,797 shares of the firm’s stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $151.01, for a total transaction of $4,348,634.97. Following the transaction, the chief executive officer now owns 307,444 shares in the company, valued at approximately $46,427,118.44. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Marc N. Casper sold 30,000 shares of the firm’s stock in a transaction on Thursday, September 1st. The stock was sold at an average price of $151.17, for a total value of $4,535,100.00. Following the transaction, the chief executive officer now owns 308,647 shares in the company, valued at approximately $46,658,166.99. The disclosure for this sale can be found here. Corporate insiders own 0.52% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.